Adn-426 C May 2026

: The trial isn't just looking for a "yes or no" on effectiveness. It is mapping the immune response in real-time, allowing scientists to iterate and improve the vaccine design almost immediately. Local Leadership

—often referred to in trial contexts as part of the ADN-426 C study. What is 426c.Mod.Core-C4b? ADN-426 C

: Instead of testing vaccine components one by one over decades, researchers are administering multiple components—like 426c and BG505 SOSIP—together with advanced adjuvants to trigger a more robust response. Real-Time Mapping : The trial isn't just looking for a